Cytosorbents (CTSO) Share-based Compensation (2010 - 2026)
Cytosorbents' (CTSO) quarterly Share-based Compensation came in at $544000.0 in Q1 2026, down 33.5% YoY from $818000.0 in Q1 2025, and down 38.6% on a QoQ basis from $886000.0 in Q4 2025.
Cytosorbents (CTSO) Share-based Compensation (2010 - 2026) Analysis & Trends
Cytosorbents (CTSO) has 17 years of Share-based Compensation data on file, last reported at $544000.0 in Q1 2026.
- Quarterly Share-based Compensation fell 33.5% year-over-year to $544000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.8 million (down 22.08% YoY) and the FY2025 annual result came in at $2.8 million, down 26.46% from the prior year.
- Share-based Compensation declined to $544000.0 in Q1 2026, from $886000.0 in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $2.1 million in Q3 2025 to a low of $2024.0 in Q1 2024.
- A 5-year average of $879135.2 and a median of $886000.0 in 2025 frame the typical range for Share-based Compensation.
- Annual changes were most pronounced in 2024 — Share-based Compensation plunged 99.81% — and 2025, when it soared 40315.02%.
- Tracing CTSO's Share-based Compensation over 5 years: stood at $870000.0 in 2022, then increased by 22.79% to $1.1 million in 2023, then slipped by 13.88% to $920000.0 in 2024, then decreased by 3.7% to $886000.0 in 2025, then tumbled by 38.6% to $544000.0 in 2026.
- The last three Share-based Compensation figures came in at $544000.0 (Q1 2026), $886000.0 (Q4 2025), and $2.1 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 168.00 Mn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 7.00 Mn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 95.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 87.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 42.20 Mn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 39.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 45.00 Mn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 94.15 Mn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.80 Mn |
| 10 | Cytosorbents | 19.47 Mn | 15.06 Mn | 7.05 Mn | 368,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 368,000.00 |
| Jun 30, 2026 | 368,000.00 |
| Mar 31, 2026 | 544,000.00 |
| Mar 31, 2026 | 544,000.00 |
| Dec 31, 2025 | 886,000.00 |
| Dec 31, 2025 | 886,000.00 |
| Sep 30, 2025 | 2.10 Mn |
| Sep 30, 2025 | 2.10 Mn |
| Jun 30, 2025 | 571,000.00 |
| Jun 30, 2025 | 571,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Mar 31, 2025 | 818,000.00 |
| Dec 31, 2024 | 920,000.00 |
| Dec 31, 2024 | 920,000.00 |
| Sep 30, 2024 | 891,000.00 |
| Sep 30, 2024 | 891,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Jun 30, 2024 | 989,000.00 |
| Mar 31, 2024 | 2,024.00 |
| Mar 31, 2024 | 2,024.00 |